224 related articles for article (PubMed ID: 36237137)
1. Detection of disease-causing CFTR variants in state newborn screening programs.
McGarry ME; Ren CL; Wu R; Farrell PM; McColley SA
Pediatr Pulmonol; 2023 Feb; 58(2):465-474. PubMed ID: 36237137
[TBL] [Abstract][Full Text] [Related]
2. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
[TBL] [Abstract][Full Text] [Related]
3. Variation in cystic fibrosis newborn screening algorithms in the United States.
Rehani MR; Marcus MS; Harris AB; Farrell PM; Ren CL
Pediatr Pulmonol; 2023 Mar; 58(3):927-933. PubMed ID: 36507555
[TBL] [Abstract][Full Text] [Related]
4. Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
McGarry ME; Sciortino S; Graham S; Bishop T; Gibb ER
Pediatr Pulmonol; 2024 Jun; ():. PubMed ID: 38940324
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.
McGarry ME; McColley SA
Pediatr Pulmonol; 2021 Jun; 56(6):1496-1503. PubMed ID: 33470563
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.
Pique L; Graham S; Pearl M; Kharrazi M; Schrijver I
Genet Med; 2017 Jan; 19(1):36-44. PubMed ID: 27148940
[TBL] [Abstract][Full Text] [Related]
7. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.
; Borowitz D; Parad RB; Sharp JK; Sabadosa KA; Robinson KA; Rock MJ; Farrell PM; Sontag MK; Rosenfeld M; Davis SD; Marshall BC; Accurso FJ
J Pediatr; 2009 Dec; 155(6 Suppl):S106-16. PubMed ID: 19914443
[TBL] [Abstract][Full Text] [Related]
8. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
[TBL] [Abstract][Full Text] [Related]
9. Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis.
Castellani C; Simmonds NJ; Barben J; Addy C; Bevan A; Burgel PR; Drevinek P; Gartner S; Gramegna A; Lammertyn E; Landau EEC; Middleton PG; Plant BJ; Smyth AR; van Koningsbruggen-Rietschel S; Girodon E; Kashirskaya N; Munck A; Nährlich L; Raraigh K; Sermet-Gaudelus I; Sommerburg O; Southern KW
J Cyst Fibros; 2023 Nov; 22(6):963-968. PubMed ID: 37775442
[TBL] [Abstract][Full Text] [Related]
10. Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.
Fevola C; Dolce D; Tosco A; Padoan R; Daccò V; Claut L; Schgor T; Sepe A; Timpano S; Fabrizzi B; Piccinini P; Taccetti G; Bonomi P; Terlizzi V
Eur J Pediatr; 2024 Feb; 183(2):929-938. PubMed ID: 38054992
[TBL] [Abstract][Full Text] [Related]
11. CFTR genotype analysis of Asians in international registries highlights disparities in the diagnosis and treatment of Asian patients with cystic fibrosis.
Vaidyanathan S; Trumbull AM; Bar L; Rao M; Yu Y; Sellers ZM
Genet Med; 2022 Oct; 24(10):2180-2186. PubMed ID: 35857025
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
[TBL] [Abstract][Full Text] [Related]
13. Distribution of pathogenic variants in the CFTR gene in a representative cohort of people with cystic fibrosis in the Kingdom of Bahrain.
Majed OAK; Majed FO; Almoamen NJ; Alsatrawi HB; Shehabi SD; Hrbková J; Libik M; Macek M
Mol Genet Genomics; 2024 May; 299(1):52. PubMed ID: 38744777
[TBL] [Abstract][Full Text] [Related]
14. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
[TBL] [Abstract][Full Text] [Related]
16. High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results.
Ginsburg DK; Salinas DB; Cosanella TM; Wee CP; Saeed MM; Keens TG; Gold JI
J Cyst Fibros; 2023 May; 22(3):420-426. PubMed ID: 36528525
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
[TBL] [Abstract][Full Text] [Related]
18. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
[TBL] [Abstract][Full Text] [Related]
19. Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening.
McColley SA; Martiniano SL; Ren CL; Sontag MK; Rychlik K; Balmert L; Elbert A; Wu R; Farrell PM
J Cyst Fibros; 2023 Jan; 22(1):89-97. PubMed ID: 35871976
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
